Latest International Expansion News

Pureprofile delivered a record FY26 with $65 million revenue, 25% EBITDA growth, and a 74% surge in platform revenue, driven by international expansion and technology adoption.

Credit Clear Limited has posted a 28% revenue increase to $60 million and a 41% jump in underlying EBITDA to $10.4 million for FY26, beating guidance and driven by organic growth and recent acquisitions in Europe and debt collection.

Monvia Limited, an Australian SaaS provider for life insurers, is seeking to raise $17.5 million via an IPO on the ASX. The funds will support redemption of preference shares and fuel growth in existing and new markets.

AFT Pharmaceuticals has received tentative US FDA approval for its Scomara cream to treat Facial Angiofibromas in Tuberous Sclerosis, but US commercialisation is postponed until 2029 due to orphan drug exclusivity. The approval bolsters regulatory prospects in other key markets where AFT anticipates competitive advantages.

Hydrix has landed a A$3.4 million contract with US-based Remedy Robotics to develop safety-critical software and embedded electronics for the N1 robotic system, marking a major step in its medical robotics ambitions.

ECS Botanics delivered a fourth consecutive quarter of positive operating cash flow in Q4 FY26, with a full-year turnaround of $5.9 million. The company’s branded B2C revenue surged 31% year-on-year, supported by product launches and European market expansion.

Activeport’s Global Edge platform has secured contracts with Spark and ViewQwest, setting the stage for a significant uplift in recurring revenue and international expansion.

Latrobe Magnesium has secured a binding $16 million funding deal with Long State Investment to complete commissioning and expand its Demonstration Plant, marking a crucial step towards commercial magnesium metal production.

Orthocell Limited has posted record revenue for FY2026, driven by strong sales growth of Remplir™ and Striate+™ products in Australia, the US, and new international markets, supported by a robust $44.1 million cash position.

SPC Global reported solid Q4 FY26 growth driven by domestic beverage sales and a 50.8% jump in international revenue, while a $100 million equity raise slashed net leverage and paved the way for improved cash flow in FY27.

WhiteHawk has landed a 90-day sole-source contract worth A$356,000 to deploy its Cyber Risk Radar in a major U.S. Government cyber resilience program, supporting around 400 organisations. This initial foothold could unlock wider adoption across critical infrastructure sectors.

Memphasys has locked in a three-year exclusive distribution agreement for its Felix™ sperm separation system in Thailand, targeting a key IVF market with 110 clinics and 20,000–30,000 cycles annually. The deal adds approximately A$430,500 in contracted revenue, lifting South-East Asian minimum contracts to about A$1 million and contributing to FY2026 Felix™ sales now exceeding A$3 million.